It is noteworthy that Sun and coworkers have reported that 66.7% of multiparous heterozygous transgenic females vs. 45% of multiparous homozygous transgenic females develop mammary tumors, suggesting that the relation between Cripto expression levels and tumor development is not so obvious. The gene discussed is CRIPTO; the disease is breast cancer.